Gdanskie Centrum Zdrowia Sp. z o.o.
- Address
- lock Available on a paid plan
Nervous System Diseases
The department is investigating core nervous system disorders such as Autism spectrum disorder and Tourette Syndrome through studies that assess new therapeutic agents and their impact on social communication and tic severity.
- Improving social interaction in ASD
- Reducing tic frequency and severity
- Assessing long‑term safety of investigational drugs
At Gdanskie Centrum Zdrowia these trials aim to expand safe treatment options for young patients across Europe.
Behavior and Behavior Mechanisms
Research targets the underlying behavioral mechanisms of conditions like irritability in children with autism, exploring how novel compounds can modify mood and interaction patterns.
- Irritability management in ASD
- Behavioral response to pitolisant
- Safety monitoring in pediatric populations
The work supports the hospital’s goal to enhance quality of life for patients with neurodevelopmental challenges.
Mental Disorders
Studies focus on mental disorders including Tourette’s and autism‑related symptoms, evaluating efficacy of emerging therapies and their tolerability over extended periods.
- Long‑term tolerability of pimavanserin
- Efficacy of gemlapodect for tic reduction
- Comprehensive assessment of ASD symptom domains
Findings from these investigations contribute to a broader understanding of psychiatric care in the Polish healthcare system.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Emalex Biosciences Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Gdanskie Centrum Zdrowia Sp. z o.o.
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Gemlapodect in Adult and Adolescent Tourette Syndrome: A Double-Blind, Placebo-Controlled, Phase IIb Study | Noema Pharma AG | Phase II | Not Recruiting | Jul 2024 | Jan 2026 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ecopipam Hydrochloride | 2 | Unknown | 2023-07-20 | 2024-04-30 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.